Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prev...

Full description

Bibliographic Details
Main Authors: Maria Skaalum Petersen, Marin Strøm, Debes Hammershaimb Christiansen, Jógvan Páll Fjallsbak, Eina Hansen Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, Shahin Gaini, Lars Fodgaard Møller, Bjarni Steig, Pál Weihe
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-11-01
Series:Emerging Infectious Diseases
Subjects:
coronavirus disease
2019 novel coronavirus disease
COVID-19
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
respiratory diseases
Online Access:https://wwwnc.cdc.gov/eid/article/26/11/20-2736_article

Internet

https://wwwnc.cdc.gov/eid/article/26/11/20-2736_article

Similar Items